TGM2 and celiac disease: An exploratory study published in 2013 [27] examined the effect of larazotide acetate on intestinal permeability, development of antibodies to tTG and celiac disease symptoms during a gluten challenge that exceeded the likely level of accidental gluten ingestion in individuals whose disease was well controlled by a GFD.